Efficacy of combination therapy for patients with chronic prostatitis/chronic pelvic pain syndrome: A prospective study

Korean Journal of Urology

Volumn 47, Issue 5, 2006, Pages 536-540

  Mo, Kyo Ik ^a   Lee, Kyung Seop ^a   Kim, Dae Gon ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Adrenergic alpha blockers; Antibiotics; Chronic disease; Pelvic pain

Indexed keywords

ALFUZOSIN; LEVOFLOXACIN;

ADJUVANT THERAPY; ADULT; ARTICLE; CHRONIC PROSTATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PELVIS PAIN SYNDROME; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 33746424827     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.5.536     Document Type: Article

References (14)

1. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/ chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004;141:581-9
2. Shoskes DA, Hakim L, Ghoniem G, Jackson CL. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003;169:1406-10
3. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first national institutes of health international prostatitis collaborative network. Urology 1999;54:229-33
4. Barbalias GA. Prostatodynia or painful male urethral syndrome? Urology 1990;36:146-53
5. Nickel JC. The three as of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? BJU Int 2004;94:1230-3
6. Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004;93:991-5
7. Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003;169: 1401-5
8. Woo YN. Prostatitis. Korean J Urol 1994;35:575-85
9. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology 1996;48:715-22
10. Kim SW, Ha JS, Lee SJ, Cho YH, Yoon MS. Clinical effect of tamsulosin in noninflammatory chronic pelvic pain syndrome. Korean J Urol 2003;44:120-3
11. Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/ chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004;171:1594-7
12. Nickel JC, Downey J, Johnston B, Clark J, Canadian Prostatitis Research Group. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001; 165:1539-44
13. Goto T, Makinose S, Ohi Y, Yamauchi D, Kayajima T, Nagayama K, et al. Diffusion of piperacillin, cefotiam, minocycline, amikacin, and ofloxacin into the prostate. Int J Urol 1998;5: 243-6
14. Mehik A, Alas P, Nickel JC, Satpola A, Helstrom PJ. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003;62:425-9